z-logo
open-access-imgOpen Access
Activity of plazomicin compared with other aminoglycosides against isolates from European and adjacent countries, including Enterobacteriaceae molecularly characterized for aminoglycoside-modifying enzymes and other resistance mechanisms
Author(s) -
Mariana Castanheira,
Lalitagauri M. Deshpande,
Leah N. Woosley,
Alisa W. Serio,
Kevin M. Krause,
Robert K. Flamm
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky344
Subject(s) - aminoglycoside , enterobacteriaceae , microbiology and biotechnology , enterobacteriaceae infections , enzyme , biology , antibiotics , escherichia coli , genetics , biochemistry , gene
Plazomicin is a next-generation aminoglycoside that was developed to overcome common aminoglycoside-resistance mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom